Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
240268 | Procedia Chemistry | 2015 | 8 Pages |
Infection disease after biomedical implant surgery is often caused by unintentional contamination of micro-organism. Novobiocin is one of the most attractive antibiotic due to its high activity against gram positive bacteria and its relatively compatible to fibroblast cell line. Based on the molecular structure of novobiocin, it may be conjugated or coated onto material surfaces. The coating steps were plasma polymerisation, polymer grafting, and novobiocin conjugation. XPS analysis showed that the elements and high resolution of C 1s confirmed that the surface chemical had changed. Novobiocin, after conjugation, became more dominant in covering the surface. Antibacterial Assay to Staphylococcus epidermidis by using dead and live kit indicated the reduction of bacteria reached up to 97.27% and only 0.07% of live bacteria left. This result led to a conclusion that immobilised novobiocin may be considered as novel antibacterial coating that can prevent nosocomial infection.